Author: RCG Admin

Congratulations to Arthur Sletton for receiving the 2017 David F. Silbert Outstanding Teaching Assistant Award.

The 2016-2017 David F. Silbert Outstanding Teaching Assistant Award foes to Mr. Arthur Sletton for his work in the 2016 Fall Human Body course. Mr. Sletton was nominated by Drs. Kari Allen, Glenn Conroy and Jane Phillips-Conroy. Mr. Sletton exemplified the spirit of this award through his dedication and lasting contribution to the course, the course instructors, and the students in the class. (more…)

Membrane Protein Structure in Live Cells: Methodology for Studying Drug Interaction by Mass Spectrometry-Based Footprinting.

Shen G., Li S., Cui W., Liu S., Yang Y., Gross M., & Li W. (2017). “Membrane Protein Structure in Live Cells: Methodology for Studying Drug Interaction by Mass Spectrometry-Based Footprinting.” Biochemistry. 2018 Jan 23;57(3):286-294. doi: 10.1021/acs.biochem.7b00874. Epub 2017 Dec 20. (Abstract)

Selective depletion of uropathogenic E. coli from the gut by a FimH antagonist.

Spaulding C.N., Klein R.D., Ruer S., Kau A.L., Schreiber H.L., Cusumano Z.T., Dodson K.W., Pinkner J.S., Fremont D.H., Janetka J.W., Remaut H., Gordon J.I., & Hultgren S.J. (2017). “Selective depletion of uropathogenic E. coli from the gut by a FimH antagonist.” Nature. 2017 Jun 22;546(7659):528-532. doi: 10.1038/nature22972. Epub 2017 Jun 14. (Abstract)

Technical Advance: New in vitro method for assaying the migration of primary B cells using an endothelial monolayer as substrate.

Stewart-Hutchinson P.J., Szasz T.P., Jaeger E.R., Onken M.D., Cooper J.A., & Morley S.C. (2017). “Technical Advance: New in vitro method for assaying the migration of primary B cells using an endothelial monolayer as substrate.” J Leukoc Biol. 2017 Sep;102(3):941-948. doi: 10.1189/jlb.1TA0117-008R. Epub 2017 Jun 21. (Abstract)

Jim Janetka’s work featured in The Source

Congratulations to Jim Janetka, whose work on UTI treatments was featured in The Source.

Dr. Janetka helped with a new study that may prevent the common problem of recurrent urinary tract infections with the use of a molecular decoy that targets e. coli bacteria.

You can read more about the work in the The Source by clicking HERE or on the picture of e. coli.

Pedal the Cause – Happy Hour Fundraiser

Please join us for a Happy Hour at itap in the Central West End to raise money for cancer research! Sixty percent of sales of the designated beer will be donated (beer TBA). Feel free to stay around after Happy Hour for itap’s weekly trivia night too!

The event will be on Thursday, June 15th, from 4 PM to 7 PM.

More information and links can be found on HERE.

Targeting the tumor-promoting microenvironment in MET-amplified NSCLC cells with a novel inhibitor of pro-HGF activation.

Owusu B.Y., Thomas S., Venukadasula P., Han Z., Janetka J.W., Galemmo R.A. Jr., & Klampfer L. (2017). “Targeting the tumor-promoting microenvironment in MET-amplified NSCLC cells with a novel inhibitor of pro-HGF activation.” Oncotarget. 2017 May 29;8(38):63014-63025. doi: 10.18632/oncotarget.18260. eCollection 2017 Sep 8. (Abstract)

Small Molecule Bacterial Lectin Antagonists for UTI Treatment and Prevention

January 30th, 2017 – Jim Janetka, PhD, Associate Professor of Biochemistry and Molecular Biophysics and Chemistry Adjunct, along with Scott Hultgren, PhD, Helen L. Stoever Professor of Molecular Microbiology received and a four year grant award from the National Institute of Diabetes and Digestive and Kidney Diseases for his research entitled “Small Molecule Bacterial Lectin Antagonists for UTI Treatment and Prevention”.